Bee Venom and Its Therapeutic Potential

Abstract

The aim of this review is to evaluate the biological effects of the major components of bee venom (apitoxin) and the implications of these effects in experimental disease models. Bee venom has become an important natural agent in modern pharmacology and medicine due to its diverse bioactive constituents, including melittin, apamin, adolapin, phospholipase A₂, and hyaluronidase. In neurodegenerative and autoimmune disease models such as Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, bee venom has been shown to exhibit neuroprotective, anti-inflammatory, and antioxidant activities. However, its toxic effects must be assessed as carefully as its therapeutic properties. Immune reactions triggered by bee venom may lead to severe clinical manifestations, particularly in allergic individuals. In conclusion, although bee venom possesses a broad therapeutic potential, its clinical application is not considered appropriate without establishing optimal treatment duration, dosing regimens, and targeted delivery strategies. Therefore, further data are needed to support the development of biotherapeutic approaches aimed at enabling the safe and effective use of bee venom.

Keywords

• Apitherapy
• Bee Venom
• Apitoxin

Arı Zehri ve Terapötik Potansiyeli

Abstract

Bu derlemenin amacı, arı zehrinin (apitoksin) başlıca bileşenlerinin biyolojik etkilerini ve bu etkilerin deneysel modellerdeki yansımalarını değerlendirmektir. Arı zehri, melittin, apamin, adolapin, fosfolipaz A₂ ve hyaluronidaz gibi çeşitli biyoaktif bileşenleri sayesinde modern farmakoloji ve tıpta önemli bir doğal ajan hâline gelmiştir. Parkinson, Alzheimer ve multipl skleroz gibi nörodejeneratif ve otoimmün hastalık modellerinde, arı zehrinin nöroprotektif, anti-inflamatuar ve antioksidan etkiler sergilediği ortaya konmuştur. Bununla birlikte, terapötik etkileri kadar toksik etkileri de dikkatle değerlendirilmelidir. Arı zehrine bağlı gelişen immün yanıtlar, özellikle alerjik bireylerde ciddi klinik tablolara neden olabilmektedir. Sonuç olarak, arı zehrinin terapötik potansiyeli oldukça geniştir. Ancak uygulama süresi, doz rejimi ve hedefe yönelik stratejiler geliştirilmeden klinik kullanıma geçilmesi uygun görülmemektedir. Bu nedenle, arı zehrinin kullanılabilmesi amacıyla biyoterapötik yaklaşımların geliştirilmesine yönelik bilimsel çalışmaların sürdürülebilmesi için daha fazla veriye ihtiyaç vardır.

Keywords

• Apiterapi
• Arı Zehri
• Apitoksin

References

1. Abdel-Monsef, M.M., Zidan, H.A., Darwish, D.A., Masoud, H.M., Helmy, M.S., & Ibrahim, M.A. (2020). Biochemical isolation and characterization of hyaluronidase enzyme from venom of Egyptian honeybee Apis mellifera Lamarckii. Journal of Apicultural Science, 64(1), 153–164. https://doi.org/10.2478/jas-2020-0015
2. Ahmed-Farid, O.A., Taha, M., Bakeer, R.M., Radwan, O.K., Hendawy, H.A.M., Soliman, A. S., & Yousef, E. (2021). Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson’s disease rat model. Scientific Reports, 11(1), 21141. https://doi. org/10.1038/s41598-021-00764-y
3. Alvarez-Fischer, D., Noelker, C., Vulinović, F., Grünewald, A., Chevarin, C., Klein, C., ... Hartmann, A. (2013). Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model. PLoS ONE, 8(4), e61700. https://doi.org/10.1371/journal. pone.0061700
4. Bava, R., Castagna, F., Musella, V., Lupia, C., Palma, E., & Britti, D. (2023). Therapeutic use of bee venom and potential applications in veterinary medicine. Veterinary Sciences, 10(2), 119. https://doiorg/10.3390/vetsci10020119
5. Buku, A., Price, J. A., Mendlowitz, M., & Masur, S. (2001). Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding. Peptides, 22(12), 1993–1998. https://doi. org/10.1016/S0196-9781(01)00542-3
6. Burzyńska, M., & Piasecka-Kwiatkowska, D. (2021). A review of honeybee venom allergens and allergenicity. International Journal of Molecular Sciences, 22(16), 8371. https://doi.org/10.3390/ ijms22168371
7. Carli, T., Locatelli, I., Košnik, M., Bevk, D., & Kukec, A. (2025). Epidemiology and risk factor analysis of systemic allergic reaction to bee venom in the Slovenian population of beekeepers. Slovenian Journal of Public Health, 64(1), 40–48. https://doi.org/10.2478/ sjph-2025-0006
8. Carpena, M., Nuñez-Estevez, B., Soria-Lopez, A., & Simal-Gandara, J. (2020). Bee venom: an updating review of ıts bioactive molecules and ıts health applications. Nutrients, 12(11), 3360. https://doi. org/10.3390/nu12113360

9. Ceremuga, M., Stela, M., Janik, E., Gorniak, L., Synowiec, E., Sliwinski, T., ... Bijak, M. (2020). Melittin-a natural peptide from bee venom which ınduces apoptosis in human leukaemia cells. Biomolecules, 10(2), 247. https://doi.org/10.3390/biom10020247
10. Chung, H.J., Lee, J., Shin, J.S., Kim, M.R., Koh, W., Kim, M.J., ... Ha, I.H. (2016). In vitro and in vivo anti-allergic and anti-inflammatory effects of eBV, a newly developed derivative of bee venom, through modulation of IRF3 signaling pathway in a carrageenan- induced edema model. PloS One, 11(12), e0168120. https://doi. org/10.1371/journal.pone.0168120
11. Cui, Z., Zhou, Z., Sun, Z., Duan, J., Liu, R., Qi, C., & Yan, C. (2024). Melittin and phospholipase A2: promising anti-cancer candidates from bee venom. Biomedicine & Pharmacotherapy, 179, 117385. https://doi. org/10.1016/j.biopha.2024.117385
12. Du, G., He, P., Zhao, J., He, C., Jiang, M., Zhang, Z., ... Sun, X. (2021). Polymeric microneedle-mediated transdermal delivery of melittin for rheumatoid arthritis treatment. Journal of Controlled Release: Official Journal of the Controlled Release Society, 336, 537–548. https://doi.org/10.1016/j.jconrel.2021.07.005
13. Gajski, G., Leonova, E., & Sjakste, N. (2024). Bee venom: composition and anticancer properties. Toxins, 16(3), 117. https://doi. org/10.3390/toxins16030117
14. Gu, H., Han, S.M., & Park, K.K. (2020). Therapeutic effects of apamin as a bee venom component for non-neoplastic disease. Toxins, 12(3), 195. https://doi.org/10.3390/toxins12030195
15. Haktanir, I., Masoura, M., Mantzouridou, F.T., & Gkatzionis, K. (2021). Mechanism of antimicrobial activity of honeybee (Apis mellifera) venom on Gram-negative bacteria: Escherichia coli and Pseudomonas spp. AMB Express, 11(1), 54. https://doi. org/10.1186/s13568-021-01214-8
16. Han, S.M., Lee, G.G., & Park, K.K. (2012). Acute dermal toxicity study of bee venom (Apis mellifera L.) in rats. Toxicological Research, 28(2), 99–102. https://doi.org/10.5487/TR.2012.28.2.099
17. Hanafi, M.Y., Zaher, E.L.M., El-Adely, S.E.M., Sakr, A., Ghobashi, A.H.M., Hemly, M.H., ... Kamel, M.A. (2018). The therapeutic effects of bee venom on some metabolic and antioxidant parameters associated with HFD-induced non-alcoholic fatty liver in rats. Experimental and Therapeutic Medicine, 15(6), 5091–5099. https://doi.org/10.3892/ etm.2018.6028
18. Hood, J.L., Jallouk, A.P., Campbell, N., Ratner, L., & Wickline, S.A. (2013). Cytolytic nanoparticles attenuate HIV-1 infectivity. Antiviral Therapy, 18(1), 95–103. https://doi.org/10.3851/IMP2346
19. Jamasbi, E., Mularski, A., & Separovic, F. (2015). Model membrane and cell studies of antimicrobial activity of melittin analogues. Current Topics in Medicinal Chemistry, 16(1), 40–45. https://doi.org/10.217 4/1568026615666150703115919
20. Jelodar, S., Zare Mirakabadi, A., Oryan, S., & Mohammadnejad, L. (2021). Effect of honey bee venom on experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Archives of Razi Institute, 76(6), 1727–1733. https://doi. org/10.22092/ARI.2021.126291.1342
21. Jung, S.Y., Lee, K.W., Choi, S.M., & Yang, E.J. (2015). Bee venom protects against rotenone-induced cell death in NSC34 motor neuron cells. Toxins, 7(9), 3715–3726. https://doi.org/10.3390/toxins7093715Kang, D.W., Choi, J.G., Kim, J., Park, J.B., Lee, J.H., & Kim, H.W. (2021). Bee venom reduces burn-induced pain via the suppression of peripheral and central substance P expression in mice. Journal of Veterinary Science, 22(1), e9. https://doi.org/10.4142/jvs.2021.22. e9
22. Kang, S.Y., Roh, D.H., Yoon, S.Y., Moon, J.Y., Kim, H.W., Lee, H.J., ... Lee, J.H. (2012). Repetitive treatment with diluted bee venom reduces neuropathic pain via potentiation of locus coeruleus noradrenergic neuronal activity and modulation of spinal NR1 phosphorylation in rats. The Journal of Pain, 13(2), 155–166. https://doi.org/10.1016/j. jpain.2011.10.012
23. Khleifat, K.M., Al-Tawarah, N.M., Al-Kafaween, M.A., Al-Ksasbeh, W., Qaralleh, H., Alqaraleh, M., ... Mohd Hilmi, A.B. (2023). Memory enhancing and neurogenesis activity of honey bee venom in the symptoms of amnesia: using rats with amnesia-like Alzheimer’s disease as a model. Current Alzheimer Research, 20(3), 190–201. https://doi.org/10.2174/1567205020666230614143027
24. Kim, J.I., Yang, E.J., Lee, M.S., Kim, Y.S., Huh, Y., Cho, I.H., ... Koh, H.K. (2011). Bee venom reduces neuroinflammation in the MPTP- induced model of Parkinson’s disease. International Journal of Neuroscience, 121(4), 209–217. https://doi.org/10.3109/0020745 4.2010.548613
25. Kim, J.Y., Leem, J., & Park, K.K. (2020). Antioxidative, antiapoptotic, and anti-inflammatory effects of apamin in a murine model of lipopolysaccharide-induced acute kidney injury. Molecules, 25(23), 5717. https://doi.org/10.3390/molecules25235717
26. Koburova, K.L., Michailova, S.G., & Shkenderov, S.V. (1985). Further investigation on the antiinflammatory properties of adolapin— bee venom polypeptide. Acta Physiologica Et Pharmacologica Bulgarica, 11(2), 50–55.
27. Lee, G., & Bae, H. (2016). Bee venom phospholipase a2: yesterday’s enemy becomes today’s friend. Toxins, 8(2), 48. https://doi. org/10.3390/toxins8020048
28. Lin, Y., Bogdanov, M., Lu, S., Guan, Z., Margolin, W., Weiss, J., & Zheng, L. (2018). The phospholipid-repair system LplT/Aas in Gram- negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack. The Journal of Biological Chemistry, 293(9), 3386–3398. https://doi.org/10.1074/jbc.RA117.001231
29. Lu, J., Zhao, Z., Pan, L., Wu, H., Wang, S., Tong, X., & Wu, S. (2025). Hyaluronidase: structure, mechanism of action, diseases and therapeutic targets. Molecular Biomedicine, 6, 50. https://doi. org/10.1186/s43556-025-00299-y
30. Mau, N.N., Quan, L.V., Du, P.V., Thanh, T.V., Thanh, N.H., Quang, N.B., ... Mao, C.V. (2024). Anti-inflammatory, analgesic, and motor improvement effects of bee venom acupuncture on Freund’s complete adjuvant-induced spinal degeneration in rats. Tropical Journal of Natural Product Research (TJNPR), 8(11), 9166–9173. https://doi.org/10.26538/tjnpr/v8i11.27
31. Mingomataj, E.C., & Bakiri, A.H. (2012). Episodic hemorrhage during honeybee venom anaphylaxis: potential mechanisms. Journal of Investigational Allergology & Clinical Immunology, 22(4), 237–244.
32. Nitecka-Buchta, A., Buchta, P., Tabeńska-Bosakowska, E., Walczyńska- Dragoń, K., & Baron, S. (2014). Myorelaxant effect of bee venom topical skin application in patients with RDC/TMD Ia and RDC/ TMD Ib: a randomized, double blinded study. BioMed Research International, 2014, 1–9. https://doi.org/10.1155/2014/296053
33. Oršolić, N. (2012). Bee venom in cancer therapy. Cancer and Metastasis Reviews, 31(1–2), 173–194. https://doi.org/10.1007/s10555-011- 9339-3
34. Pedro, G., Brasileiro, F.C. da S., Ferreira, R.S., Bráz, A.M.M., & Laufer- Amorim, R. (2025). Melittin inhibits proliferation, migration, and invasion in osteosarcoma cell lines using 2D and 3D models. The Journal of Venomous Animals and Toxins Including Tropical Diseases, 31(40), e20240053. https://doi.org/10.1590/1678-9199- JVATITD-2024-0053
35. Rizkallah, J., Charbel, N., Yassine, A., El Masri, A., Raffoul, C., El Sardouk, O., ... Kreidieh, F. (2025). Melittin-based nanoparticles for cancer therapy: mechanisms, applications, and future perspectives. Pharmaceutics, 17(8), 1019. https://doi.org/10.3390/ pharmaceutics17081019
36. Roh, D.H., Kim, H.W., Yoon, S.Y., Kang, S.Y., Kwon, Y.B., Cho, K.H., ... Lee, J.H. (2006). Bee venom injection significantly reducesnociceptive behavior in the mouse formalin test via capsaicin- insensitive afferents. The Journal of Pain, 7(7), 500–512. https:// doi.org/10.1016/j.jpain.2006.02.002
37. Sadek, K.M., Shib, N.A., Taher, E.S., Rashed, F., Shukry, M., Atia, G.A., ... Abdeen, A. (2024). Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review. Frontiers in Pharmacology, 15. https://doi.org/10.3389/ fphar.2024.1412245
38. Sarhan, M., El-Bitar, A.M.H., & Hotta, H. (2020). Potent virucidal activity of honeybee “Apis mellifera” venom against hepatitis C virus. Toxicon: Official Journal of the International Society on Toxinology, 188, 55–64. https://doi.org/10.1016/j.toxicon.2020.10.014
39. Shi, W., Li, C., Li, M., Zong, X., Han, D., & Chen, Y. (2016). Antimicrobial peptide melittin against Xanthomonas oryzae pv. oryzae, the bacterial leaf blight pathogen in rice. Applied Microbiology and Biotechnology, 100(11), 5059–5067. https://doi.org/10.1007/ s00253-016-7400-4
40. Socarras, K.M., Theophilus, P.A.S., Torres, J.P., Gupta, K., & Sapi, E. (2017). Antimicrobial activity of bee venom and melittin against Borrelia burgdorferi. Antibiotics, 6(4), 31. https://doi.org/10.3390/ antibiotics6040031
41. Somwongin, S., Chantawannakul, P., & Chaiyana, W. (2018). Antioxidant activity and irritation property of venoms from Apis species. Toxicon, 145, 32–39. https://doi.org/10.1016/j.toxicon.2018.02.049
42. Sorucu, A. (2019). Arı ürünleri ve apiterapi. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni, 10(1), 1–15.
43. Stela, M., Cichon, N., Spławska, A., Szyposzynska, M., & Bijak, M. (2024). Therapeutic potential and mechanisms of bee venom therapy: a comprehensive review of apitoxin applications and safety enhancement strategies. Pharmaceuticals, 17(9), 1211. https://doi.org/10.3390/ph17091211
44. Uddin, M.B., Lee, B.H., Nikapitiya, C., Kim, J.H., Kim, T.H., Lee, H.C., ... Kim, C.J. (2016). Inhibitory effects of bee venom and its components against viruses in vitro and in vivo. Journal of Microbiology (Seoul, Korea), 54(12), 853–866. https://doi.org/10.1007/s12275-016- 6376-1
45. Ullah, A., Aldakheel, F.M., Anjum, S.I., Raza, G., Khan, S.A., & Tlak Gajger, I. (2023). Pharmacological properties and therapeutic potential of honey bee venom. Saudi Pharmaceutical Journal : SPJ, 31(1), 96–109. https://doi.org/10.1016/j.jsps.2022.11.008
46. Wang, K., Tao, L., Zhu, M., Yu, X., Lu, Y., Yuan, B., & Hu, F. (2024). Melittin ınhibits colorectal cancer growth and metastasis by ac-tivating the mitochondrial apoptotic pathway and suppressing epithelial– mesenchymal transition and angiogenesis. International Journal of Molecular Sciences, 25(21), 11686. https://doi.org/10.3390/ ijms252111686
47. Wehbe, R., Frangieh, J., Rima, M., El Obeid, D., Sabatier, J.M., & Fajloun, Z. (2019). Bee venom: overview of main compounds and bioactivities for therapeutic interests. Molecules, 24(16), 2997. https://doi.org/10.3390/molecules24162997
48. Zan, H., Liu, J., Yang, M., Zhao, H., Gao, C., Dai, Y., ... Zhang, Y. (2024). Melittin alleviates sepsis-induced acute kidney injury by promoting GPX4 expression to inhibit ferroptosis. Redox Report: Communications in Free Radical Research, 29(1), 2290864. https:// doi.org/10.1080/13510002.2023.2290864
49. Zhang, S.F., & Chen, Z. (2017). Melittin exerts an antitumor effect on non‐small cell lung cancer cells. Molecular Medicine Reports, 16(3), 3581–3586. https://doi.org/10.3892/mmr.2017.6970